Trial reportClinical orthopaedics and related research2016
Ultrashort versus Conventional Anatomic Cementless Femoral Stems in the Same Patients Younger Than 55 Years.
Trial report in Clinical orthopaedics and related research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Long-term outcomes of total hip arthroplasty in patients younger than 55 years: a systematic review of the contemporary literatureCanadian journal of surgery. Journal canadien de chirurgie · 2019Pooled it
- Pooled it
- Pooled it
- Results of an Ultra Short Metaphyseal Filling Cementless Stem in Primary Total Hip Arthroplasty: Mean 12.1-Year Follow-up.Indian journal of orthopaedics · 2026Article
- Article
- Fifteen-Year Follow-Up of Nanos Neck-Preserving Hip Arthroplasty: An Observational Retrospective Study.Journal of functional morphology and kinesiology · 2025Article
- Short Stem vs. Standard Stem in Primary Total Hip Replacement: A Perioperative Prospective Invasiveness Study with Serum Markers.Diseases (Basel, Switzerland) · 2025Article
- Preserved periprosthetic bone stock at 5 years post-operatively with uncemented short hip stem in both collared and collarless version.Archives of orthopaedic and trauma surgery · 2022Article
- Comparison of Femoral Bone Mineral Density Changes around 3 Common Designs of Cementless Stems after Total Hip Arthroplasty-A Retrospective Cohort Study.Orthopaedic surgery · 2022Article
- Comparison of short-stem versus conventional stem for hip arthroplasty in patients younger than 60 years: 7-14 years follow-up.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2022Article
- Mid-term results of short versus conventional cementless femoral stems in patients with bilateral osteonecrosis of the femoral head.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2022Article
- Ultra-Short Bone Conserving Cementless Femoral Stem.Hip & pelvis · 2021Review
- Short-term success of proximal bone stock preservation in short hip stems: a systematic review of the literature.EFORT open reviews · 2021Review
- Fragility Index as a Measure of Randomized Clinical Trial Quality in Adult Reconstruction: A Systematic Review.Arthroplasty today · 2021Article
- Hydroxyapatite-coated cementless total hip arthroplasty for patients undergoing dialysis: a study of 30 hips with a minimum follow-up period of 5 years.BMC musculoskeletal disorders · 2021Article
- Short versus conventional stem in cementless total hip arthroplasty : An evidence-based approach with registry data of mid-term survival.Der Orthopade · 2021Article
- Mid-term results of short-stem total hip arthroplasty in patients with Crowe type I and II developmental dysplasia of the hip.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2021Article
- A comparison of short-stem prostheses and conventional stem prostheses in primary total hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials.Annals of translational medicine · 2021Article
- Lower limb joint repair and replacement: an overview.F1000Research · 2019Review
- Interest of short implants in hip arthroplasty for osteonecrosis of the femoral head: comparative study "uncemented short" vs "cemented conventional" femoral stems.International orthopaedics · 2018Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBecause the clinical and radiographic performance of an ultrashort anatomic cementless stem has been investigated in only two randomized controlled studies, well-designed trials should aim for a thorough comparison of the outcomes of ultrashort anatomic cementless and conventional anatomic cementless stems. QUESTIONS/PURPOSES: The purposes of this study were to compare (1) the clinical results, including Harris hip score, thigh pain, and WOMAC index score, (2) radiographic results, (3) bone mineral density; and (4) proportions of patients undergoing revision of a THA using an ultrashort anatomic cementless stem versus a conventional anatomic cementless stem in the same patients who underwent bilateral sequential THAs under the same anesthetic.
methodsTwo hundred patients (mean age, 53 years; range, 26-54 years) who underwent bilateral sequential THAs received an ultrashort anatomic cementless stem in one hip and a conventional anatomic cementless stem in the contralateral hip. From January 2004 to December 2005, we performed 524 same-day bilateral short and conventional anatomic cementless THAs in 262 patients, of whom 212 (81%) participated in this study. Five patients were lost to followup before 2 years, five were lost between 2 to 10 years, and two were lost between 10 to 13 years, leaving 200 patients. Patients who had end-stage bilateral hip disease and were younger than 55 years were selected for inclusion. The predominant diagnoses were osteonecrosis (118 patients, 59%) and osteoarthritis (44 patients, 22%). One hundred thirty-eight were men and 62 were women. At the time of each followup, the patients were assessed clinically and radiographically. In addition, each patient completed the WOMAC and the University of California Los Angeles (UCLA) activity scores. The minimum followup was 10 years (mean, 11.8 years; range, 10-13 years). Followups were done in person, with all images and followup clinic notes. Based on the power analysis, we estimated a sample size of 178 hips was needed in each group to detect a 3-point difference in the Harris hip score with 80% power.
resultsAt the latest followup, there were no differences between the two groups regarding the mean Harris hip scores (94 versus 94 points; p = 0.189), mean WOMAC scores (17 versus 16 points; p = 0.191), or mean UCLA activity scores (9 versus 9 points; p = 0.381). Two patients in the ultrashort stem group and one patient in the conventional stem group had severe (9 points) thigh pain, and 30 patients (15%) in the conventional stem group had mild thigh pain (2 or 3 points) after vigorous exercise. Bone mineral density in the ultrashort and conventional stem groups, respectively, was greater in the ultrashort stem group than in the conventional stem group. Bone mineral density in Zone 1 at 12 years was 3.29 versus 1.88 g/cm(2) (p = 0.021), and 2.97 versus 0.91 g/m(2) in Zone 7 (p = 0.001). With the numbers available, there were no differences between the stem designs in terms of the proportion undergoing revision (one hip, 0.5%, in the short-stem group versus one hip, 0.5%, in the conventional group; p = 1.881).
conclusionsAt followup into the second decade, ultrashort stems showed no differences from conventional cementless stems in terms of validated outcomes scores or fixation, although less stress shielding was observed. Reduction of stress shielding may reduce the long-term risk of periprosthetic fracture, but this was not shown in our study. LEVEL OF EVIDENCE: Level I, therapeutic study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.